Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer immunotherapy

CD4+ CAR T cells — more than helpers

Nature Cancer volume 4, pages 928–929 (2023)Cite this article

Subjects

Therapeutic products containing CD8+ and CD4+ T cells expressing CARs are effective at inducing remission in patients with cancer. How CD4+ CAR T cells contribute to the anti-tumor response has not been well established. A study uses syngeneic models and in vivo imaging to glean mechanistic insights into how CD4+ T cells target tumors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: CD4+ CAR T cells target tumors using multiple mechanisms.

References

  1. Melenhorst, J. J. et al. Nature 602, 503–509 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Oh, D. Y. & Fong, L. Immunity 54, 2701–2711 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ridge, J. P., Di Rosa, F. & Matzinger, P. Nature 393, 474–478 (1998).

    Article  CAS  PubMed  Google Scholar 

  4. Boulch, M. et al. Sci. Immunol. 6, eabd4344 (2021).

    Article  CAS  PubMed  Google Scholar 

  5. Borst, J., Ahrends, T., Bąbała, N., Melief, C. J. M. & Kastenmüller, W. Nat. Rev. Immunol. 18, 635–647 (2018).

    Article  CAS  PubMed  Google Scholar 

  6. Christopher, M. J. et al. N. Engl. J. Med. 379, 2330–2341 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Toffalori, C. et al. Nat. Med. 25, 603–611 (2019).

    Article  CAS  PubMed  Google Scholar 

  8. Walsh, Z., Yang, Y. & Kohler, M. E. Immunol. Rev. 290, 100–113 (2019).

    Article  CAS  PubMed  Google Scholar 

  9. Boulch, M. et al. Nat. Cancer https://doi.org/10.1038/s43018-023-00570-7 (2023).

    Article  PubMed  Google Scholar 

  10. Sommermeyer, D. et al. Leukemia 30, 492–500 (2016).

    Article  CAS  PubMed  Google Scholar 

  11. Bove, C. et al. J. Immunother. Cancer 11, e005878 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Yang, Y. et al. Sci. Transl Med. 9, eaag1209 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wang, D. et al. JCI Insight 3, e99048 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ishii, K. et al. J. Clin. Invest. 130, 5425–5443 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

    M. Eric Kohler & Terry J. Fry

  2. Center for Cancer and Blood Disorders, Children’s Hospital Colorado, Aurora, CO, USA

    M. Eric Kohler & Terry J. Fry

Authors
  1. M. Eric Kohler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Terry J. Fry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Eric Kohler.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kohler, M.E., Fry, T.J. CD4+ CAR T cells — more than helpers. Nat Cancer 4, 928–929 (2023). https://doi.org/10.1038/s43018-023-00567-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-023-00567-2

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer